Hearing Aids + Health Education for Age-Related Hearing Loss
(EARHLI Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Hearing Aids + Health Education for Age-Related Hearing Loss?
Research shows that educational programs, like multimedia-based education, can improve knowledge and self-confidence in managing hearing aids, which helps people use them more effectively. Additionally, collaboration between healthcare providers and home services can enhance practical skills and satisfaction with hearing aid use.12345
Is the combination of hearing aids and health education safe for humans?
The available research on health education programs, including those for older adults, suggests they are generally safe and focus on improving knowledge and behavior related to health. There is no specific safety data on the combination of hearing aids and health education, but health education interventions are typically non-invasive and safe.678910
How is the Hearing Aids + Health Education treatment for age-related hearing loss different from other treatments?
This treatment is unique because it combines hearing aids with a health education program, which helps users understand and effectively use their hearing aids, improving communication skills and overall quality of life. Unlike traditional treatments that focus solely on fitting hearing aids, this approach includes educational resources and communication strategies to address the broader challenges of hearing loss.1112131415
What is the purpose of this trial?
Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).
Research Team
Justin S Golub, MD
Principal Investigator
Columbia University
Eligibility Criteria
The EARHLI trial is for late middle-aged adults who are experiencing early age-related hearing loss and may be at risk for cognitive decline or Alzheimer's Disease. Participants will be followed for a year to see if interventions help.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a hearing intervention or a health education intervention. The hearing intervention includes 4 sessions across 8 weeks with a booster session and hearing aid fitting.
Follow-up
Participants are monitored for cognitive decline, social engagement, and changes in brain organization/connectivity. Assessments occur at study start, 6 months, and 12 months.
Extension
Participants in the health education group receive hearing aids at the end of their 12-month participation.
Treatment Details
Interventions
- Health Education Intervention
- Hearing Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
University of Washington
Collaborator
National Institute on Aging (NIA)
Collaborator
University of South Florida
Collaborator
University of Pittsburgh
Collaborator
Johns Hopkins University
Collaborator